Use of carboxyhaemoglobin levels to predict the development of diseases associated with cigarette smoking. Carboxyhaemoglobin (COHb) levels in tobacco smokers vary throughout the day since they are affected by the pattern of tobacco consumption and the rate at which COHb is eliminated. A method is described whereby a single COHb measurement together with a recent smoking history may be used to estimate the average COHb 'boost' produced by each cigarette, the total daily carbon monoxide (CO) uptake from smoking, and the mean COHb level throughout the day. These three indices of tobacco smoke absorption were estimated in nine healthy cigarette smokers on different days, each set of three estimations being derived from separate COHb determinations. The indices were reasonably reproducible within the same person, and the differences between people were statistically highly significant (P<0-001). For example, the estimates of mean daily COHb level resulting from smoking ranged from 0-7% to 9 3% in smokers who smoked 15 to 40 cigarettes a day. These differences are sufficiently large to distinguish possible differences in the risk of developing diseases such as ischaemic heart disease which may result from the inhalation and absorption of tobacco smoke. The suggested indices also depend less on the time of the blood test and on the daily pattern of smoking than a COHb level alone. The ratio of the COHb boost to the CO yield of a cigarette may reflect depth of inhalation more accurately than a smoker's self-assessment. Moreover there was little correlation between these two measures of inhalation in the nine subjects studied.
Men aged 4049 years who smoke 20 cigarettes per day are about 10 to 15 times more likely to die of lung cancer and about three times more likely to die of ischaemic heart disease than nonsmokers (Doll and Hill, 1964; Hammond, 1971) . The likely reason for this difference in relative risk is that smoking is the main cause of lung cancer while other factors such as hypertension and serum cholesterol level influence the risk of developing ischaemic heart disease (Kannel et al., 1961; Kannel et al., 1971) . What is perhaps more puzzling is that some individuals smoke 20 cigarettes per day throughout their lives with little apparent ill effect. Some of the difference in the risk of developing these diseases among such smokers may be genetically determined (Deutscher, Ostrander, and Epstein, 1970; Kellermann, Shaw, and Luyten-Kellerman, 1973 ), but the degree to which tobacco smoke is inhaled and absorbed is also likely to be important. In some studies information has been collected on self-reported inhalation habits, but the results of such studies have been conflicting (Doll and Hill, N. Wald, Susannah Howard, P. G. Smith, and A. Bailev prevalence of ischaemic heart disease (Wald et al., 1973) , a single measurement of COHb probably does not adequately reflect a smoker's exposure to CO since the COHb level at any time is affected not only by the amount of CO absorbed from each cigarette but also by the pattern of recent tobacco consumption and by the rate at which CO is eliminated. The purpose of this paper is to show how a single measurement of COHb, together with details of the subject's recent smoking history and level of activity, can be used to estimate the amount of CO absorbed from each cigarette, and thus the total CO absorbed each day and the mean daily COHb level.
THEORY
In this paper the COHb derived from the CO absorbed from each cigarette smoked is referred to as the 'COHb boost'. The size of this boost depends on various factors, such as the brand of cigarette smoked, the depth of inhalation, and the number of puffs per cigarette. We have assumed that, in a particular smoker, the boost produced by each cigarette smoked during the day is identical. After smoking a cigarette, the rate of elimination of CO from the blood is principally determined by the ventilation rate and the pulmonary transfer factor for CO. Figure 1 , constructed from data given by Coburn, Forster, and Kane (1965) , demonstrates the relationship between COHb half-life, alveolar ventilation, and activity. We have measured the half-life of COHb for four sedentary and five moderately active cigarette smokers. These smokers were asked to stop smoking for one hour, and venous blood samples were taken immediately and one hour later. The mean COHb half-life in the sedentary subjects was 2 3 hours (range 133-34) and in moderately active subjects was 11 hours (range 06-13) (Wilcoxon test P <001). These values are in reasonable agreement with Fig. 1 and other data (Ashton and Telford, 1973; Russell et al., 1973) . From this Figure it may be noted that at low levels of activity the rate of decay increases considerably for relatively small increases in activity.
The contribution of the COHb boost per cigarette to a smoker's COHb level decreases exponentially with the time since the cigarette was smoked, the half-life depending on the smoker's activity. Each cigarette may, thus, be considered separately and, at any time during the day, the excess of the COHb level above 'background' may be considered to be the sum of the (Lawther and Commins, 1970 Lawther (1965) , and all estimations were performed using two aliquots of each blood sample. The COHb level was taken as the average of the estimations from the two aliquots which, in general, were within 02% of each other. Each subject had samples taken in the afternoon on between two and eight different days. The subjects had not been asked to alter their normal smoking habits. Each time a blood sample was taken a questionnaire was completed on the time of waking, the time that each cigarette was smoked on the day of the test, the number of cigarettes smoked in each two-hour period of the previous day, and the time of going to sleep. The brand of cigarette smoked, the usual number smoked per day, and the subject's estimate of his normal depth of inhalation (nil, slight, moderate, or deep) were also recorded. They were not asked to keep a running record of the number of cigarettes smoked and were not informed of the experiment until the day of the test. The CO yield of each brand of cigarette smoked was determined using a smoking machine under standard conditions (Tobacco Research Council, 1972) .
Similar data were later collected from six of the subjects on three separate mornings shortly after they had arrived at work. Again they were not asked to alter their normal smoking habits.
The level of activity of each subject during the 24 hours preceding the blood test was classified as sedentary (e.g., typing at a desk with little movement from the desk), light activity (e.g., typing with frequent departures from the desk), and moderately active (continuous walking about). Using Fig. 1 , the COHb half-lives corresponding to these levels of activity were taken as 2j hours, 2 hours, and 1 hour respectively. The COHb half-life during sleep was taken as 4 hours. The usual level of activity was recorded in the same categories. None of the subjects was involved in heavy manual work.
RESULTS
Details of the nine healthy subjects and the CO yields of the brands of cigarette they smoked are shown in Table I . The difference in CO yields between the various brands tested are significantly different (F ratio (8,12 df)=19-1; P <0001), the estimate of the within-brand variance being 0-9 ml2. Table II shows the mean values for the nine subjects of the following five indices of tobacco smoke absorption:
(i) usual number of cigarettes smoked each day; (ii) COHb level at the time the blood sample was taken; (iii) estimated COHb boost per cigarette, assuming exponential decay of COHb with a half-life of 4 hours while asleep and of 24 hours, 2 hours, and 1 hour during the day, depending on level of activity on the day of the test; (iv) estimated total daily CO uptake expressed in COHb%, i.e., the product of indices (i) and (iii); (v) estimated mean COHb level above 'background' over 24 hours, derived from the total CO uptake (iv) in conjunction with an estimate of the subject's usual COHb daytime half-life, made on the basis of his normal activity. (The indices which are computed from a COHb measurement were based upon blood samples taken in the afternoon.) Table II also shows the ranks for each index. Variance ratio (F) tests indicate that, for each of these indices, the differences between subjects are highly significant. Figure 2 shows the COHb boost per cigarette (as in (iii) above) estimated from blood sanPles and smoking questionnaires from the same subjects on different days. Figure  3 shows, in a similar way, the estimated mean COHb levels. Although there is day-to-day variability, some subjects are consistently different from others. Table IV shows, for each subject, the ratio of the COHb boost per cigarette to the CO yield of their brand of cigarette and the self-assessed inhalation rating. history, subjects were reasonably confident that information relating to smoking on the day of the blood test (the day the questionnaire was completed) was correct. They were less confident about such information relating to the previous day, but since the residual COHb from that day is very small in comparison with that produced on the day of the test, any associated error is unlikely to be important. The method of estimating COHb per cigarette that we propose computes an average of the boosts from each individual cigarette. It has been assumed that the boost produced by a cigarette is not dependent upon the COHb level at the time of starting to smoke the cigarette. This assumption may not be completely justified but the variation in boost that such an effect might produce is likely to be small compared with the 'random' variation in boost from cigarette to cigarette, such as from varying the number of puffs per cigarette. It is also likely that any dependence of boost on COHb level will vary from person to person. We therefore consider it reasonable to assume a constant boost for each cigarette.
The COHb boost per cigarette will depend on the method of smoking (the size and number of puffs and the depth of inhalation), the pulmonary transfer factor, and the CO yield from the cigarette. The between-person variation in transfer factor is about twofold (Filley, MacIntosh, and Wright, 1954) , and apart from Embassy Extra Mild the between-brand variation in CO yield of cigarettes smoked in this study is even smaller (Table I ). Cigarettes such as Embassy Extra Mild which have perforated filter tips have low CO yields, but they are also unusual in several other respects and there is evidence that smoking such cigarettes may result in deeper inhalation of the smoke (Wald and Smith, 1973) . The betweenperson variation in COHb boost per cigarette is at least tenfold (Fig. 3) . This indicates that the method of smoking is the main factor affecting COHb boost per cigarette, although from the data collected in this study it is not possible to isolate the independent effects of size of puff, number of puffs, or depth of inhalation. This is probably not of practical importance since a disease resulting from smoking is likely to be associated with all three factors. The ratio of the COHb boost per cigarette to the CO yield of the cigarette provides an objective measure of these factors combined. As shown in Table IV , this ratio does not correlate with a person's opinion of his depth of inhalation and this may account for some of the conflicting results of studies using self-reported inhalation habits. In this study the CO yield of cigarettes was determined under standard laboratory conditions and while the results are likely to reflect the actual CO yield, when these cigarettes are smoked normally the yields will not always be the same as the laboratory results. The COHb boost per cigarette will also depend on a person's total haemoglobin and myoglobin content. In general, these are relatively unimportant determinants of COHb levels, and they have not been considered in our calculations. The COHb boost per cigarette is also likely to decrease with age and with the development of lung disease although there will also be a compensatory decrease in the rate of elimination of COHb.
The three indices of tobacco smoke absorption shown in Table II , COHb boost, CO uptake, and mean daily COHb level, are all reasonably reproducible within the same subject and are sufficiently different between groups of subjects to distinguish possible differences in risk. A comparison of columns (iv) and (v) shows the results of allowing for usual activity levels; for example, subject DR is apparently at fairly low risk according to his CO uptake, but as he is normally sedentary his COHb during the day is high. Tables  II and III suggest that there is greater random variation in these indices than in the COHb measurements themselves. However, the indices are, on average, independent of the time of taking blood whereas the COHb levels are not.
It is not possible to say which of the measures of risk we have discussed will correlate best with the incidence of disease in a prospective study, or indeed if any of them are better than simply the amount smoked. It is likely that the 'best' measure would be different for different diseases. Cholesterol deposition into the aorta of a rabbit is greater as a result of intermittent CO administration than with continuous exposure, even though the rate of administration is the same in both cases (Astrup, 1972) , and thus a further possible predictor of disease is the 'peak' COHb value during the day. We have not calculated this value in cur subjects, but if data are collected in the way we have described this could easily be done.
CO is only one of many constituents of tobacco smoke but the absorption of other constituents in the smoke might be related to the CO uptake. This is likely to be the case for other constituents which, like CO, are absorbed through the lungs, although the precise extent of the absorption may depend on other factors such as the pH of the smoke. In a particular brand of cigarette, by relating the CO yield to that of another constituent, the pulmonary intake of this other constituent can be estimated. If CO is itself harmful, then it is likely to be less harmful in an active person who eliminates it more rapidly and has a lower mean COHb level, whereas the effect of other harmful constituents which may not be reduced by activity will be better reflected by CO uptake, or 
